HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 409 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $371,775 | 0.0% | 9,139 | 0.0% | 0.06% | 0.0% |
| Q1 2024 | $371,775 | +10.4% | 9,139 | +0.3% | 0.06% | 0.0% |
| Q4 2023 | $336,816 | -27.4% | 9,113 | -25.0% | 0.06% | -33.3% |
| Q3 2023 | $463,863 | -35.8% | 12,143 | -39.4% | 0.09% | -32.8% |
| Q2 2023 | $722,951 | +10.3% | 20,043 | +0.9% | 0.13% | -34.0% |
| Q1 2023 | $655,577 | -33.9% | 19,872 | +2.5% | 0.20% | -36.0% |
| Q4 2022 | $991,319 | +24.2% | 19,392 | -3.9% | 0.32% | +1.3% |
| Q3 2022 | $798,000 | – | 20,183 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 14,092,771 | $206,177,000 | 28.12% |
| BB BIOTECH AG | 8,322,860 | $121,763,000 | 3.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 398,633 | $4,579,000 | 2.84% |
| DOHENY ASSET MANAGEMENT /CA | 227,193 | $3,324,000 | 2.43% |
| SNYDER CAPITAL MANAGEMENT L P | 2,833,759 | $41,458,000 | 2.24% |
| First Light Asset Management, LLC | 938,399 | $13,729,000 | 2.19% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,027,164 | $132,067,000 | 1.77% |
| Taylor Wealth Management Partners | 204,277 | $2,989,000 | 1.72% |
| Sterling Global Strategies LLC | 22,000 | $321,860,000 | 1.63% |
| Granite Investment Partners, LLC | 988,939 | $14,468,000 | 1.06% |